Toward a Complete Set of Germline Null and Modifiable Mutations in Drosophila

果蝇中一整套种系无效突变和可修饰突变

基本信息

  • 批准号:
    8779682
  • 负责人:
  • 金额:
    $ 21.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2017-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The overall goal of this proposal is to generate, maintain, and distribute a new collection of engineered Drosophila melanogaster stocks that will allow versatile manipulation of genes for which there is currently no mutant allele available. Using cutting edge CRISPR technology, this collection or 'kit' will represent a powerful new set of tools that will benefit virtually all Drosophila geneticists, and it is likely that there will b a high demand for this resource for many years. Many of the most important advances in our understanding of human development have come from studies using Drosophila as an animal model system. Since many parallels exist between Drosophila and mammals in terms of the underlying molecular mechanisms controlling biological processes, knowledge gained from research in Drosophila can be either directly applied or readily adapted to understanding human biology. One key factor that sets Drosophila apart from other model systems is the huge wealth of genetic and molecular tools that have accumulated in the past 100 years of research. To study any given gene, two essential reagents are loss-of-function mutations and a tagged version of the gene. Currently available methods to obtain mutant or tagged alleles of genes cover only a portion of the genome or are inefficient, laborious, and time consuming. Indeed, there are more than 2000 genes in the fly genome that currently lack a mutant allele with no means of efficiently generating either a loss-of-function mutant or a tagged allele. To address this problem, we propose to generate a new targeted collection that will complement existing collections and offer the ultimate flexibility of downstream manipulation, such as generating both point and loss-of-function mutations, protein tagging, and gene expression profiling. We plan to split this project into two phases: Phase I will serve as a proof of principle and optimize the conditions for CRISPR- mediated targeting while Phase II will generate a collection targeting 2000 genes currently without a mutation. To achieve this goal, we will: Aim 1. Develop and optimize CRISPR-Cas9 mediated cassette targeting. Aim 2. Evaluate CRISPR-mediated cassette targeting across the genome. Success in Phase I will develop robust protocols for CRISPR-mediated cassette targeting and set the stage for expanding our effort to generate a complete collection during Phase II. Harnessing the benefits of new technologies, this collection will be another key addition to the Drosophila research tool kit. As a sign of the strong enthusiasm this proposal has received from many prominent Drosophila researchers, a set of 11 letters of support are included with this application.
描述(由申请人提供):本提案的总体目标是生成、维护和分发一批新的工程化黑腹果蝇种群,这些种群将允许对目前没有可用突变等位基因的基因进行通用操作。使用最先进的CRISPR技术,这个集合或“试剂盒”将代表一套强大的新工具,将使几乎所有的果蝇遗传学家受益,并且很可能会有B对这种资源的高需求多年。我们对人类发育的理解中许多最重要的进展都来自于使用果蝇作为动物模型系统的研究。由于果蝇和哺乳动物在控制生物过程的潜在分子机制方面存在许多相似之处,因此从果蝇研究中获得的知识可以直接应用或容易地适用于理解人类生物学。 果蝇与其他模式系统不同的一个关键因素是在过去100年的研究中积累了大量的遗传和分子工具。要研究任何给定的基因,两个基本的试剂是功能丧失突变和基因的标记版本。目前获得基因的突变或标记等位基因的可用方法仅覆盖基因组的一部分,或者效率低、费力且耗时。事实上,果蝇基因组中有2000多个基因目前缺乏突变等位基因,无法有效地产生功能丧失突变体或标记等位基因。为了解决这个问题,我们建议生成一个新的靶向集合,该集合将补充现有集合,并提供下游操作的最终灵活性,例如生成点突变和功能丧失突变、蛋白质标签和基因表达谱。我们计划将该项目分为两个阶段:第一阶段将作为原理证明并优化CRISPR介导的靶向条件,而第二阶段将产生一个针对目前没有突变的2000个基因的集合。为了实现这一目标,我们将:目标1。开发和优化CRISPR-Cas9介导的盒靶向。目标2.评估跨基因组的CRISPR介导的盒靶向。第一阶段的成功将为CRISPR介导的盒靶向开发强大的方案,并为扩大我们在第二阶段产生完整集合的努力奠定基础。利用新技术的好处,这个集合将是果蝇研究工具包的另一个关键补充。为了表明这一提议得到了许多著名果蝇研究人员的强烈支持,本申请中包括了一组11封支持信。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ming Fa其他文献

Ming Fa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ming Fa', 18)}}的其他基金

A New Tool Kit for Whole-Genome Mapping and Complementation in Drosophila
用于果蝇全基因组作图和互补的新工具包
  • 批准号:
    8252589
  • 财政年份:
    2012
  • 资助金额:
    $ 21.97万
  • 项目类别:
A New Tool Kit for Whole-Genome Mapping and Complementation in Drosophila
用于果蝇全基因组作图和互补的新工具包
  • 批准号:
    8726436
  • 财政年份:
    2012
  • 资助金额:
    $ 21.97万
  • 项目类别:
A New Tool Kit for Whole-Genome Mapping and Complementation in Drosophila
用于果蝇全基因组作图和互补的新工具包
  • 批准号:
    8593142
  • 财政年份:
    2012
  • 资助金额:
    $ 21.97万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 21.97万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 21.97万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 21.97万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 21.97万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 21.97万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 21.97万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 21.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 21.97万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 21.97万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 21.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了